# EDGAR Filing Document

**Accession Number:** 0001949257
**File Stem:** 0001213900-25-123911
**Filing Date:** 2025-12
**Character Count:** 2786
**Document Hash:** 9408127304584c78ab0eeea513d82832
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-123911.hdr.sgml**: 20260616

**ACCESSION NUMBER**: 0001213900-25-123911

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251219

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Radiopharm Theranostics Ltd
- **CENTRAL INDEX KEY:** 0001949257
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** C3
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 3, 62 LYGON STREET
- **CITY:** CARLTON VIC
- **PROVINCE COUNTRY:** C3
- **ZIP:** 3053
- **BUSINESS PHONE:** 61 3 9824 5254

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 3, 62 LYGON STREET
- **CITY:** CARLTON VIC
- **PROVINCE COUNTRY:** C3
- **ZIP:** 3053

December 19, 2025

*via EDGAR*

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

---

| | |
|:---|:---|
| **Re:** | Radiopharm Theranostics Limited |

---

Registration Statement on Form F-3

Filed December 17, 2025

File No. 333-292198

**Request for Acceleration of Effectiveness**

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, Radiopharm Theranostics Limited (the "Registrant") respectfully requests acceleration of its Registration Statement on Form F-3 (File No. 333-292198), filed on December 17, 2025, so that it will become effective at 9:00 a.m. (Eastern time) on December 23, 2025, or as soon as practicable thereafter.

If you have any questions, or require any additional information, please do not hesitate to email Andrew Reilly, the Registrant's outside counsel, at andrew.reilly@rimonlaw.com.

The Registrant acknowledges that, if the Securities and Exchange Commission (or its staff, acting pursuant to delegated authority) (the "Commission") declares the filing effective, such action:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) does not foreclose the Commission from taking any action with respect to the filing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) may not be asserted by the Registrant as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

---

| |
|:---|
| Very truly yours, |
| Radiopharm Theranostics Limited |
| /s/ Riccardo Canevari |
| Riccardo Canevari |
| Chief Executive Officer and <br> Managing Director |

---